Molecular Characterization Of Drug Resistance in Plasmodium falciparum
A prospective study designed to identify molecular markers of antimalarial drug resistance in Plasmodium falciparum in Yola, Nigeria. Objectives of the study are: 1. To detect clinically significant genes associated with antimalarial drug resistance in Plasmodium falciparum using dried blood spot (DBS) samples 2. To calculate the parasite density in patients who are malaria rapid diagnostic test (RDT) positive 3. To determine the rate of malaria infection among febrile patients presenting to the hospital 4. To determine if an infection comprises additional species of Plasmodium, such as P. vivax, P. malariae, P. ovale, and P. knowlesi 5. To assess the use of malaria control interventions.
Summary
- 35 Samples
- 1 Location
Samples/Year
QC Pass
Samples that passed Whole-Genome Sequencing Quality Control (QC)
Resistance
Predicted resistance status for main antimalarial drug treatments from molecular markers
Locations
Adamawa
Summary
Samples/Year
QC Pass
Samples that passed Whole-Genome Sequencing Quality Control (QC)
Resistance
Predicted resistance status for main antimalarial drug treatments from molecular markers